Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model.
Paolo Dell'OglioDanny M van WilligenMatthias N van OosteromKevin BauwensFabian HensbergenMick M WellingHuijbert van der StadtElise BekersMartin PoolPim van LeeuwenTobias MaurerFijs W B van LeeuwenTessa BucklePublished in: EJNMMI research (2022)
allowed tumor identification in human prostate samples, underlining the translational potential of this novel tracer. Trial registration Approval for use of biological material for research purposes was provided by the Translational Research Board of the Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital (NKI-AvL) under reference IRBm19-273 (22/10/2019).
Keyphrases
- radical prostatectomy
- robot assisted
- prostate cancer
- fluorescence imaging
- pet imaging
- photodynamic therapy
- minimally invasive
- positron emission tomography
- endothelial cells
- papillary thyroid
- pet ct
- study protocol
- clinical trial
- healthcare
- induced pluripotent stem cells
- squamous cell
- phase ii
- computed tomography
- pluripotent stem cells
- childhood cancer
- randomized controlled trial
- lymph node metastasis
- risk assessment
- climate change
- drug administration
- electronic health record